¡Únete a nuestro equipo en SOMOS LÍNEA!Somos una empresa dedicada a la comercialización de ropa de dama, especializados en bonetería, es decir, toda la variante de calcetines y mallones. Estamos buscando personas apasionadas por las ventas...
EMPRESA DE GRAN PRESENCIA EN EL SECTOR MATERIAL ELÉCTRICO SE ENCUENTRA DE AUXILIAR DE RECURSOS HUMANOSAuxiliar de Recursos Humanos "**Requisitos**:- Edad: De 25 a 30 años- Escolaridad: Lic. Administración y o Psicología (Titulada o pasante...
**Descripción del empleo**Empresa dedicada a la fabricación de canceleria y persianas esta contratando:PRACTICANTE DE OPERACIONES**Requisitos**:- Estudiante de la carrera de: Ingeniera Industrial, Administración, carreras afín.- Únicamente ...
Fender Musical Instruments Corporation is a world-famous brand with offices across the globe. Fender was born in Southern California and has built a worldwide influence beyond the studio and the stage. A Fender is more than an instrument; i...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »